CASE REPORT |
|
Year : 2022 | Volume
: 1
| Issue : 1 | Page : 35-38 |
|
Efficacy of Hiranyatutta for managing a case of joint pain in secondary hamochromatosis in beta thalassemia major: A pilot case study
Manjiri Ranade
Department of Rasa Shastra, Sri Sai Ayurvedic Medical College, Aligarh, Uttar Pradesh, India
Correspondence Address:
Dr. Manjiri Ranade Department of Rasa Shastra, Sri Sai Ayurvedic Medical College, GT Rd, opp. Phal Mandi, Sarsol, Aligarh 202002, Uttar Pradesh India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/jahas.jahas_2_21
|
|
Thalassemias are hereditary globin-producing diseases caused by mutations in the globin gene. In the Indian subcontinent, it is a major concern, particularly among individuals of lower socioeconomic status. Although there is no curative treatment, frequent blood transfusions are required to delay mortality. Although regular blood transfusions are required, they do have health effects. Secondary hemochromatosis (iron overload) is a condition in which the iron in red blood cells accumulates in various body parts as a result of frequent blood transfusions. Secondary hemochromatosis can cause a range of symptoms depending on the organs involved, but the most common and severe symptom is joint pain, which affects the patient not only physically but also mentally. We treated one patient with this condition using Hiranyatutta, a novel ayurvedic medication, and the outcomes were promising. An 18-year-old boy was suffering from this chronic condition since the last 2 years. Joint discomfort and swelling persisted to the point that the patient’s activities of daily life were hampered. The disease activity score using 28 joint counts (DAS28) rating technique gives a score of 5.8 for the baseline severity. Over 3 months, the patient’s symptoms gradually improved. This condition is identical to Vata-Rakta in the Ayurvedic medical system. Traditional approaches to the potential of successful management are being explored as modern sciences have management constraints. With actions such as Tridoshaghna, Vatashamaka, Raktashod-haka, and Vedanahara, therefore alleviating the signs and symptoms of Vata-Rakta, this drug has a synergistic role in breaking the pathophysiology of Vata-Rakta. Though the condition cannot be completely cured, it can be effectively managed and controlled. Because of the suffering associated with the condition, the costs suffered by the patient, and with the objective of bringing relief to the hurting society from this condition, the use of an ayurvedic holistic approach might be valuable. |
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|